Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This is a phase II trial of abraxane and carboplatin in extensive stage small cell lung
cancer to examine overall response rate, time to progressive disease, survival time, and
assessment of toxicity profile for Carboplatin and Abraxane.